NG
NervGen Pharma Corp. Common stock (NGEN)
NASDAQ·Healthcare·Biotechnology
$2.18
+2.35%
Mkt Cap $180.41M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (1 analysts)
$12.00
Range $12.00 – $12.00
Implied Upside
+450.5%
Consensus $12.00 vs current $2.18